Literature DB >> 25299918

The scope of patent protection for gene technology in China.

Wei Li1, LiSheng Cai1.   

Abstract

Mesh:

Year:  2014        PMID: 25299918     DOI: 10.1038/nbt.3031

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Analyzing the protection scope limit for biosequence patent claims in China.

Authors:  Wei Li
Journal:  Nat Biotechnol       Date:  2018-09-06       Impact factor: 54.908

2.  The morality and ethics governing CRISPR-Cas9 patents in China.

Authors:  Yaojin Peng
Journal:  Nat Biotechnol       Date:  2016-06-09       Impact factor: 54.908

3.  Patenting human genes: Chinese academic articles' portrayal of gene patents.

Authors:  Li Du
Journal:  BMC Med Ethics       Date:  2018-04-24       Impact factor: 2.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.